Developer docs
API playgroundTry for free, no card

Search company profiles

SigutLabs

Full company profile

uuid005bb44

Namestring
SigutLabs
Legal namestring
SigutLabs s.r.o.
Websiteurl
sigutlabs.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

SigutLabs s.r.o. is a Prague-based contract research organization (CRO) specializing in organic, bioorganic, and medicinal chemistry. The firm was founded around 2010 by CEO Krystof Sigut (rebranded from Santiago Labs in September 2024) and operates from a laboratory at Radiova 1285/7 in Prague, Czech Republic, with a billing entity registered at Minická 189. SigutLabs is wholly founder-owned, with no disclosed institutional investors, parent company, or subsidiaries, and runs an all-PhD technical team led by Head of Research Petr Slavik.

The company delivers three core service lines: (1) Custom Synthesis of previously reported molecules via known procedures, (2) Contract Research developing novel synthetic routes to undescribed compounds, and (3) Scale-Up services transitioning laboratory quantities to industrial batches. Specialized chemistry domains include ADC linker-payload systems (including novel cysteine-reactive warheads such as 2-methyl(sulfonyl)pyrimidine), nucleoside and nucleotide chemistry, peptide and click-chemistry, organometallic chemistry, and lincosamide antibiotic development. A joint international patent application (WO2018161979) is pending with the Czech Academy of Sciences on lincosamide derivatives as antimicrobial agents. Operational capabilities include an in-house purification technology demonstrated at 350 kg vitamin K2 oil scale and reported 95% on-time shipment within two days.

Revenue is generated through two contract models — Fee-for-Service (FFS) for projects with literature precedent, priced per delivery and paid only on successful completion, and Full-Time Equivalent (FTE) for novel research with monthly billing and weekly progress reporting — plus a transactional e-commerce channel at sigutlabs.com/eshop/ listing 199+ catalog research chemicals (nucleoside analogues, ADC reagents, specialty compounds) priced €100-€9,000, and listings on Scientist.com and Science Exchange marketplaces. Customers span pharmaceutical companies, biotechnology firms, and academic research institutions globally, with named partners including Scripps Research Institute, Sanford Burnham Prebys, NIH/NIEHS, ETH Zurich, Johns Hopkins, Karolinska Institutet, Université Laval, Charles University, and an unnamed California biotech startup whose ADC candidate advanced to Phase 1. Non-dilutive funding flows from EU and Czech government programmes (Technology Agency of the Czech Republic TREND, Czech Rise Up 3.0, Ministry of Industry and Trade, National Recovery Plan Creative Vouchers).

Short descriptiontext

SigutLabs is a Prague-based contract research organization providing custom synthesis, novel-route contract research, and scale-up services in organic, bioorganic, and medicinal chemistry — including ADC linkers and nucleoside chemistry — to pharmaceutical companies, biotech firms, and academic research institutions globally via FFS, FTE, and e-shop channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPrague, Czechia
HQ citystring
Prague
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research services, custom synthesis chemistry, scale-up chemistry services, medicinal chemistry CRO, nucleoside nucleotide synthesis
Industry4 codes
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Chemical Manufacturing325
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Industrial Organic Chemicals2860
Product category
Contract Research Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Custom Synthesis Services
TypeOne Time License
Description

Synthesis of previously reported molecules using described synthetic procedures for research purposes

sigutlabs.com
2Contract Research Services
TypeProfessional Services
Description

Developing novel synthetic routes for undescribed compounds in organic, bioorganic, and medicinal chemistry under FFS or FTE contract models

sigutlabs.com
3Scale-Up Services
TypeProfessional Services
Description

Lab-to-industry scaling services for clients requiring larger quantities of compounds

sigutlabs.com
4Product Sales (E-shop)
TypeOne Time License
Description

Sale of research chemicals, nucleoside/nucleotide analogues, and reagents through online storefront with prices ranging from €100 to €9000

sigutlabs.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Product-based pricing for research chemicals
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products range from €100-€9000 depending on compound complexity. Examples: T-705 ribosyl triphosphate €5000-€7000, Monomethyl auristatin E €400-€900, various nucleosides starting at €160

sigutlabs.com
2Fee for Service (FFS) for projects with literature precedent
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Price quoted before project start, paid only upon successful delivery of agreed quality product

sigutlabs.com
3Full-Time Equivalent (FTE) for challenging projects with no/limited literature precedent
ModelUsage-basedBilling cadenceMonthly
Notes

Monthly billing based on dedicated team member time; weekly progress reporting; can be short-term (1 month) or long-term (over a year)

sigutlabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SigutLabs is a contract research organization (CRO) providing custom synthesis, contract research, and lab-to-industry scale-up services in organic, bioorganic, and medicinal chemistry for pharmaceutical and biotechnology clients. The company creates custom molecules, develops novel synthetic routes for undescribed compounds, and scales laboratory chemistry to industrial production. It also sells research chemicals (nucleoside/nucleotide analogues, reagents) through its online e-shop.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 95% of shipments delivered within 2 days
+3 more records
Product overview1 text field

SigutLabs is a contract research organization (CRO) providing specialized chemistry services to pharmaceutical and biotechnology companies. The company operates as a single unified service platform offering three core service lines: Custom Synthesis for producing known molecules via reported methods, Contract Research for developing novel synthetic routes to undescribed compounds, and Scale-Up services for transitioning from laboratory to industrial production. Additionally, the company maintains an E-shop catalog of research chemicals including nucleoside/nucleotide analogues, ADC linker-payload systems, and modified compounds. The services are delivered by an all-PhD team based in Prague, Czech Republic, with global delivery capabilities including clients in Silicon Valley.

Product and service5 records
1Custom Synthesis
CategoryContract Research Services
Description

Service for creating custom molecules via known synthesis methods using reported synthetic procedures for previously described compounds. Targeted at pharmaceutical, biotechnology, and academic research clients needing access to specific known compounds.

2Contract Research
CategoryContract Research Services
Description

Service for developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry. Targeted at clients requiring new chemistry approaches where no literature precedent exists, with engagement under Fee-for-Service or Full-Time Equivalent contract models.

3Scale-Up
CategoryContract Research Services
Description

Service enabling lab-to-industry scaling with advanced instruments, helping clients transition from laboratory scales to industrial-scale production. Targeted at clients requiring larger quantities of compounds for preclinical or clinical programs (demonstrated with 30+ g lincomycin derivative scale-up).

4Nucleoside/Nucleotide Analogues (E-shop Catalog)
CategoryResearch Chemicals
Description

Catalog of research chemicals including nucleoside triphosphates, modified nucleotides, and reagents for antiviral and anticancer research applications. Sold via the SigutLabs e-shop and on scientific marketplace platforms (Scientist.com, Science Exchange).

5Large-Scale Purification Services
CategoryContract Research Services
Description

Industrial-scale purification processes for temperature-sensitive and UV-sensitive compounds. Demonstrated through a 350 kg vitamin K2 oil purification completed in 14 days, reducing the client's process from days to hours. Targeted at manufacturers requiring purification of large crude batches.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership for custom synthesis and contract research services supporting Scripps research programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research partnership supporting这家 independent medical research institute's drug discovery efforts.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership supporting NIEHS research programs with custom synthesis services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research with one of Europe's leading technical universities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ongoing collaboration including joint patent application WO2018161979 for lincosamide antibiotics development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration providing custom-synthesized compounds for academic research programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Canadian research university for custom synthesis services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration supporting university's pharmaceutical sciences research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research partnership with Finnish university.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Czech technical university for research collaboration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Czech technical university.

12Uniwersytet Gdański (University of Gdańsk)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Polish research university.

sigutlabs.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Ukraine-headquartered specialty chemistry CRO offering custom synthesis, building blocks, and screening libraries with an all-PhD-level scientific staff. Closely comparable niche focus on novel synthesis routes and catalog chemical supply, with a similar cost-efficient Eastern European operating model.

TypeBroad incumbent
Description

Large CRO network offering medicinal chemistry, custom synthesis, and ADME/tox services. Comparable on contract research and custom synthesis offerings but operating at parent-Eurofins scale with integrated in vitro and in vivo capabilities.

TypeBroad incumbent
Description

Full-service CRO/CDMO offering discovery chemistry, custom synthesis, process R&D, and scale-up. Comparable on core CRO chemistry services but with substantially broader integrated capabilities, multiple global sites, and large pharma clients.

TypeBroad incumbent
Description

Global, full-service CRO spanning discovery chemistry, safety assessment, and manufacturing. Comparable in offering custom synthesis and contract research services to pharma and biotech, though Charles River operates at vastly larger scale with publicly disclosed financials.

TypeDirect peer
Description

Asia-headquartered CRO providing discovery chemistry, custom synthesis, and process R&D services to global pharma and biotech. Comparable on FTE/FFS contract chemistry model and target customer base of pharma and biotech clients.

TypeDirect peer
Description

Specialty CRO focused on custom synthesis, building blocks, and medicinal chemistry services, with a strong online catalog of research chemicals. Directly comparable business model combining FFS custom synthesis with e-commerce reagent sales, similar in scale and customer mix.

7Syngene International
TypeBroad incumbent
Description

India-based integrated CRO/CDMO offering medicinal chemistry, custom synthesis, and development/manufacturing services. Comparable on contract research and chemistry services for global pharma, though with much broader scale and service scope.

TypeDirect peer
Description

Research chemical supplier and contract synthesis provider with deep catalog of nucleosides, nucleotides, lipids, and biochemical reagents. Comparable on e-shop product strategy and custom synthesis for research institutes and biotechs, though Cayman is much larger and more catalog-driven.

TypeBroad incumbent
Description

Global CRO/CDMO with extensive custom synthesis, medicinal chemistry, and ADC linker/payload capabilities. Directly comparable on contract research, custom synthesis, and scale-up services, but operating at vastly larger scale and offering integrated discovery-to-manufacturing workflows that SigutLabs does not.

TypeDirect peer
Description

US-based provider of screening compounds, building blocks, and custom synthesis services with a large e-commerce catalog. Comparable in combining catalog reagent sales with custom synthesis and serving medicinal chemistry research customers across pharma and academia.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SigutLabs

Contract Research Servicessigutlabs.com

SigutLabs is a Prague-based contract research organization providing custom synthesis, novel-route contract research, and scale-up services in organic, bioorganic, and medicinal chemistry — including ADC linkers and nucleoside chemistry — to pharmaceutical companies, biotech firms, and academic research institutions globally via FFS, FTE, and e-shop channels.

What SigutLabs does

SigutLabs s.r.o. is a Prague-based contract research organization (CRO) specializing in organic, bioorganic, and medicinal chemistry. The firm was founded around 2010 by CEO Krystof Sigut (rebranded from Santiago Labs in September 2024) and operates from a laboratory at Radiova 1285/7 in Prague, Czech Republic, with a billing entity registered at Minická 189. SigutLabs is wholly founder-owned, with no disclosed institutional investors, parent company, or subsidiaries, and runs an all-PhD technical team led by Head of Research Petr Slavik.

The company delivers three core service lines: (1) Custom Synthesis of previously reported molecules via known procedures, (2) Contract Research developing novel synthetic routes to undescribed compounds, and (3) Scale-Up services transitioning laboratory quantities to industrial batches. Specialized chemistry domains include ADC linker-payload systems (including novel cysteine-reactive warheads such as 2-methyl(sulfonyl)pyrimidine), nucleoside and nucleotide chemistry, peptide and click-chemistry, organometallic chemistry, and lincosamide antibiotic development. A joint international patent application (WO2018161979) is pending with the Czech Academy of Sciences on lincosamide derivatives as antimicrobial agents. Operational capabilities include an in-house purification technology demonstrated at 350 kg vitamin K2 oil scale and reported 95% on-time shipment within two days.

Revenue is generated through two contract models — Fee-for-Service (FFS) for projects with literature precedent, priced per delivery and paid only on successful completion, and Full-Time Equivalent (FTE) for novel research with monthly billing and weekly progress reporting — plus a transactional e-commerce channel at sigutlabs.com/eshop/ listing 199+ catalog research chemicals (nucleoside analogues, ADC reagents, specialty compounds) priced €100-€9,000, and listings on Scientist.com and Science Exchange marketplaces. Customers span pharmaceutical companies, biotechnology firms, and academic research institutions globally, with named partners including Scripps Research Institute, Sanford Burnham Prebys, NIH/NIEHS, ETH Zurich, Johns Hopkins, Karolinska Institutet, Université Laval, Charles University, and an unnamed California biotech startup whose ADC candidate advanced to Phase 1. Non-dilutive funding flows from EU and Czech government programmes (Technology Agency of the Czech Republic TREND, Czech Rise Up 3.0, Ministry of Industry and Trade, National Recovery Plan Creative Vouchers).

SigutLabs firmographics

Firmographics
Name
SigutLabs
Legal name
SigutLabs s.r.o.
Website
https://sigutlabs.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
SigutLabs is a Prague-based contract research organization providing custom synthesis, novel-route contract research, and scale-up services in organic, bioorganic, and medicinal chemistry — including ADC linkers and nucleoside chemistry — to pharmaceutical companies, biotech firms, and academic research institutions globally via FFS, FTE, and e-shop channels.
Ownership category
akta.pro rank

SigutLabs industry classification

Industry
Product category
Contract Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Chemical Manufacturing (325)
SIC
Services-Commercial Physical & Biological Research (8731), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Contract research services
  • Custom synthesis chemistry
  • Scale-up chemistry services
  • Medicinal chemistry CRO
  • Nucleoside nucleotide synthesis

Where SigutLabs is headquartered

Location

Headquarters

HQ city
Prague
HQ country
Czechia
HQ region
Europe

Offices2 records

Markets served

SigutLabs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Custom Synthesis Services: Synthesis of previously reported molecules using described synthetic procedures for research purposes
  2. Contract Research Services: Developing novel synthetic routes for undescribed compounds in organic, bioorganic, and medicinal chemistry under FFS or FTE contract models
  3. Scale-Up Services: Lab-to-industry scaling services for clients requiring larger quantities of compounds
  4. Product Sales (E-shop): Sale of research chemicals, nucleoside/nucleotide analogues, and reagents through online storefront with prices ranging from €100 to €9000

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goProduct-based pricing for research chemicals
Transaction based/ take ratePay-as-you-goFee for Service (FFS) for projects with literature precedent
Usage-basedMonthlyFull-Time Equivalent (FTE) for challenging projects with no/limited literature precedent

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

SigutLabs product offering

Product offering

Core offering

SigutLabs is a contract research organization (CRO) providing custom synthesis, contract research, and lab-to-industry scale-up services in organic, bioorganic, and medicinal chemistry for pharmaceutical and biotechnology clients. The company creates custom molecules, develops novel synthetic routes for undescribed compounds, and scales laboratory chemistry to industrial production. It also sells research chemicals (nucleoside/nucleotide analogues, reagents) through its online e-shop.

Product overview

SigutLabs is a contract research organization (CRO) providing specialized chemistry services to pharmaceutical and biotechnology companies. The company operates as a single unified service platform offering three core service lines: Custom Synthesis for producing known molecules via reported methods, Contract Research for developing novel synthetic routes to undescribed compounds, and Scale-Up services for transitioning from laboratory to industrial production. Additionally, the company maintains an E-shop catalog of research chemicals including nucleoside/nucleotide analogues, ADC linker-payload systems, and modified compounds. The services are delivered by an all-PhD team based in Prague, Czech Republic, with global delivery capabilities including clients in Silicon Valley.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Synthesis Service for creating custom molecules via known synthesis methods using reported synthetic procedures for previously described compounds. Targeted at pharmaceutical, biotechnology, and academic research clients needing access to specific known compounds.
  • Contract Research Service for developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry. Targeted at clients requiring new chemistry approaches where no literature precedent exists, with engagement under Fee-for-Service or Full-Time Equivalent contract models.
  • Scale-Up Service enabling lab-to-industry scaling with advanced instruments, helping clients transition from laboratory scales to industrial-scale production. Targeted at clients requiring larger quantities of compounds for preclinical or clinical programs (demonstrated with 30+ g lincomycin derivative scale-up).
  • Nucleoside/Nucleotide Analogues (E-shop Catalog) Catalog of research chemicals including nucleoside triphosphates, modified nucleotides, and reagents for antiviral and anticancer research applications. Sold via the SigutLabs e-shop and on scientific marketplace platforms (Scientist.com, Science Exchange).
  • Large-Scale Purification Services Industrial-scale purification processes for temperature-sensitive and UV-sensitive compounds. Demonstrated through a 350 kg vitamin K2 oil purification completed in 14 days, reducing the client's process from days to hours. Targeted at manufacturers requiring purification of large crude batches.

Quantifiable outcome

  • 95% of shipments delivered within 2 days
  • +3 more outcomes

Companies that use SigutLabs

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

SigutLabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

SigutLabs partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • The Scripps Research InstitutecoreStrategic or Co-development PartnerResearch partnership for custom synthesis and contract research services supporting Scripps research programs.
  • Sanford Burnham PrebyscoreStrategic or Co-development PartnerCollaborative research partnership supporting这家 independent medical research institute's drug discovery efforts.
  • National Institute of Environmental Health SciencescoreStrategic or Co-development PartnerPartnership supporting NIEHS research programs with custom synthesis services.
  • ETH ZurichcoreStrategic or Co-development PartnerCollaborative research with one of Europe's leading technical universities.
  • Institute of Organic Chemistry and Biochemistry of the Czech Academy of SciencescoreStrategic or Co-development PartnerOngoing collaboration including joint patent application WO2018161979 for lincosamide antibiotics development.
  • Johns Hopkins UniversitycoreStrategic or Co-development PartnerResearch collaboration providing custom-synthesized compounds for academic research programs.
  • Université LavalcoreStrategic or Co-development PartnerPartnership with Canadian research university for custom synthesis services.
  • University of MinnesotacoreStrategic or Co-development PartnerResearch collaboration supporting university's pharmaceutical sciences research.
  • University of TurkuminorStrategic or Co-development PartnerResearch partnership with Finnish university.
  • University of Chemistry and Technology PragueminorStrategic or Co-development PartnerPartnership with Czech technical university for research collaboration.
  • Brno University of TechnologyminorStrategic or Co-development PartnerPartnership with Czech technical university.
  • Uniwersytet Gdański (University of Gdańsk)minorStrategic or Co-development PartnerPartnership with Polish research university.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

SigutLabs competitors and assessment

Company assessment

Direct peers

  • Enamine: Ukraine-headquartered specialty chemistry CRO offering custom synthesis, building blocks, and screening libraries with an all-PhD-level scientific staff. Closely comparable niche focus on novel synthesis routes and catalog chemical supply, with a similar cost-efficient Eastern European operating model.
  • ChemPartner: Asia-headquartered CRO providing discovery chemistry, custom synthesis, and process R&D services to global pharma and biotech. Comparable on FTE/FFS contract chemistry model and target customer base of pharma and biotech clients.
  • Bide Pharmatech: Specialty CRO focused on custom synthesis, building blocks, and medicinal chemistry services, with a strong online catalog of research chemicals. Directly comparable business model combining FFS custom synthesis with e-commerce reagent sales, similar in scale and customer mix.
  • Cayman Chemical: Research chemical supplier and contract synthesis provider with deep catalog of nucleosides, nucleotides, lipids, and biochemical reagents. Comparable on e-shop product strategy and custom synthesis for research institutes and biotechs, though Cayman is much larger and more catalog-driven.
  • Combi-Blocks: US-based provider of screening compounds, building blocks, and custom synthesis services with a large e-commerce catalog. Comparable in combining catalog reagent sales with custom synthesis and serving medicinal chemistry research customers across pharma and academia.

Broad incumbents

  • Eurofins Discovery: Large CRO network offering medicinal chemistry, custom synthesis, and ADME/tox services. Comparable on contract research and custom synthesis offerings but operating at parent-Eurofins scale with integrated in vitro and in vivo capabilities.
  • Pharmaron: Full-service CRO/CDMO offering discovery chemistry, custom synthesis, process R&D, and scale-up. Comparable on core CRO chemistry services but with substantially broader integrated capabilities, multiple global sites, and large pharma clients.
  • Charles River Laboratories: Global, full-service CRO spanning discovery chemistry, safety assessment, and manufacturing. Comparable in offering custom synthesis and contract research services to pharma and biotech, though Charles River operates at vastly larger scale with publicly disclosed financials.
  • Syngene International: India-based integrated CRO/CDMO offering medicinal chemistry, custom synthesis, and development/manufacturing services. Comparable on contract research and chemistry services for global pharma, though with much broader scale and service scope.
  • WuXi AppTec (WuXi STA): Global CRO/CDMO with extensive custom synthesis, medicinal chemistry, and ADC linker/payload capabilities. Directly comparable on contract research, custom synthesis, and scale-up services, but operating at vastly larger scale and offering integrated discovery-to-manufacturing workflows that SigutLabs does not.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

SigutLabs social profiles

Digital presence

SigutLabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SigutLabs leadership team

Management profile

Number of profiles

Profiles2 records

SigutLabs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SigutLabs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SigutLabs

What does SigutLabs do?

SigutLabs is a contract research organization (CRO) providing custom synthesis, contract research, and lab-to-industry scale-up services in organic, bioorganic, and medicinal chemistry for pharmaceutical and biotechnology clients. The company creates custom molecules, develops novel synthetic routes for undescribed compounds, and scales laboratory chemistry to industrial production. It also sells research chemicals (nucleoside/nucleotide analogues, reagents) through its online e-shop.

Is SigutLabs a public or private company?

SigutLabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SigutLabs founded?

SigutLabs was founded in 2010. It employs 1 to 10 people.

Where is SigutLabs based?

SigutLabs is headquartered in Prague, Czechia, in the Europe region.

How does SigutLabs make money?

Four revenue lines are on record. Custom Synthesis Services are the primary driver. The others are contract Research Services, scale-Up Services and product Sales (E-shop).

Who are SigutLabs's main competitors?

Direct peers on record are Enamine, ChemPartner, Bide Pharmatech, Cayman Chemical and Combi-Blocks. Broad incumbents are Eurofins Discovery, Pharmaron, Charles River Laboratories, Syngene International and WuXi AppTec (WuXi STA).

Does SigutLabs have an API?

No public API is recorded for SigutLabs.

What industry is SigutLabs in?

SigutLabs's product category is Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales